Pharmaceuticals (Jul 2013)

Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study

  • El-Moukhtar Aliouat,
  • Eduardo Dei-Cas,
  • Anna Martinez,
  • Jean Jacques Vanden Eynde,
  • Sébastien Boutry,
  • Isabelle Mahieu,
  • Delphine Forge,
  • Claire Pinçon,
  • Dimitri Stanicki,
  • Muriel Pottier,
  • Nausicaa Gantois

DOI
https://doi.org/10.3390/ph6070837
Journal volume & issue
Vol. 6, no. 7
pp. 837 – 850

Abstract

Read online

Some compounds articulated around a piperazine or an ethylenediamine linker have been evaluated in vitro to determine their activity in the presence of a 3T6 fibroblast cell line and an axenic culture of Pneumocystis carinii, respectively. The most efficient antifungal derivatives, namely N,N′-bis(benzamidine-4-yl)ethane-1,2-diamine (compound 6, a diamidine) and N-(benzamidine-4-yl)-N′-phenylethane-1,2-diamine (compound 7, a monoamidine), exhibited no cytotoxicity and were evaluated in vivo in a rat model. Only the diamidine 6 emerged as a promising hit for further studies.

Keywords